作者
Zobair M Younossi, Saleh A Alqahtani, Khalid Alswat, Yusuf Yilmaz, Caglayan Keklikkiran, Jesús Funuyet-Salas, Manuel Romero-Gómez, Jian-Gao Fan, Ming-Hua Zheng, Mohamed El-Kassas, Laurent Castera, Chun-Jen Liu, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Alina M Allen, Brian Lam, Sombat Treeprasertsuk, Saeed Hameed, Hirokazu Takahashi, Takumi Kawaguchi, Jörn M Schattenberg, Ajay Duseja, Phil N Newsome, Sven Francque, C Wendy Spearman, Marlen I Castellanos Fernández, Patrizia Burra, Stuart K Roberts, Wah-Kheong Chan, Marco Arrese, Marcelo Silva, Mary Rinella, Ashwani K Singal, Stuart Gordon, Michael Fuchs, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Wayne Eskridge, Achim Kautz, Janus P Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Ming-Lung Yu, Lynn Gerber, Lisa Fornaresio, Fatema Nader, Linda Henry, Andrei Racila, Pegah Golabi, Maria Stepanova, Patrizia Carrieri, Jeffrey V Lazarus
发表日期
2024/3/1
期刊
Journal of hepatology
卷号
80
期号
3
页码范围
419-430
出版商
Elsevier
简介
Background & Aims
Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this cross-sectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) and healthcare providers.
Methods
Members of the Global NASH Council created two surveys about experiences/attitudes toward NAFLD and related diagnostic terms: a 68-item patient and a 41-item provider survey.
Results
Surveys were completed by 1,976 patients with NAFLD across 23 countries (51% Middle East/North Africa [MENA], 19% Europe, 17% USA, 8% Southeast Asia, 5% South Asia) and 825 healthcare providers (67% gastroenterologists/hepatologists) across 25 countries (39% MENA, 28% Southeast Asia, 22% USA, 6% South Asia, 3% Europe). Of all patients, 48% ever disclosed having NAFLD/NASH to family/friends; the most …
引用总数
学术搜索中的文章